Coherus BioSciences (CHRS)
(Delayed Data from NSDQ)
$1.91 USD
-0.10 (-4.98%)
Updated May 24, 2024 04:00 PM ET
After-Market: $1.91 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -0.21 |
EPS Last Quarter | -0.32 |
Last EPS Surprise | -540.00% |
ABR | 1.60 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.63 |
Next Year | 0.06 |
EPS (TTM) | -1.59 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 57.37M | 61.71M | 260.78M | 333.82M |
# of Estimates | 2 | 2 | 3 | 3 |
High Estimate | 62.00M | 65.00M | 272.00M | 357.00M |
Low Estimate | 52.73M | 58.41M | 250.33M | 305.00M |
Year ago Sales | 58.72M | 74.57M | 257.24M | 260.78M |
Year over Year Growth Est. | -2.31% | -17.25% | 1.37% | 28.01% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.21 | -0.08 | -0.63 | 0.06 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.26 | -0.11 | -0.78 | -0.12 |
High Estimate | -0.15 | -0.04 | -0.48 | 0.23 |
Low Estimate | -0.26 | -0.11 | -0.78 | -0.12 |
Year ago EPS | -0.38 | -0.27 | -1.98 | -0.63 |
Year over Year Growth Est. | 44.74% | 70.37% | 68.18% | 108.73% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.21 | -0.08 | -0.63 | 0.06 |
7 Days Ago | -0.21 | -0.08 | -0.63 | 0.06 |
30 Days Ago | -0.16 | -0.07 | -0.44 | 0.09 |
60 Days Ago | -0.16 | -0.07 | -0.44 | 0.09 |
90 Days Ago | -0.09 | 0.01 | -0.33 | 0.37 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.21 | -0.08 | -0.63 | 0.06 |
Zacks Consensus Estimate | -0.21 | -0.08 | -0.63 | 0.06 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.32 | -0.62 | -0.27 | -0.38 | NA |
Estimate | -0.05 | -0.21 | -0.21 | -0.52 | NA |
Difference | -0.27 | -0.41 | -0.06 | 0.14 | -0.15 |
Surprise | -540.00% | -195.24% | -28.57% | 26.92% | -184.22% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more